tm
Seeing Is Believing
tm
Seeing Is Believing
KYTX is currently covered by 2 analysts with an average price target of $16.26. This is a potential upside of $13.11 (416.19%) from yesterday's end of day stock price of $3.15.
Kyverna Therapeutics, Common Stock's activity chart (see below) currently has 0 price targets and 7 ratings on display. The stock rating distribution of KYTX is 28.57% BUY and 71.43% HOLD.
Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 5 days.
Highest price target for KYTX is $33, Lowest price target is $6, average price target is $19.5.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 20-Nov-2024. First documented stock forecast 04-Mar-2024.
Currently out of the existing stock ratings of KYTX, 2 are a BUY (28.57%), 5 are a HOLD (71.43%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6
$2.78 (86.34%)
$7
6 months 27 days ago
(20-Nov-2024)
4/5 (80%)
$1.88 (45.63%)
10
Buy
$33
$29.78 (924.84%)
$39
10 months 16 days ago
(31-Jul-2024)
0/2 (0%)
$24.34 (281.06%)
What is KYTX (Kyverna Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on KYTX (Kyverna Therapeutics, Common Stock) with a proven track record?
Which analyst has the current lower performing score on KYTX (Kyverna Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on KYTX (Kyverna Therapeutics, Common Stock)?
Which analyst is the currently most bullish on KYTX (Kyverna Therapeutics, Common Stock)?
Which analyst is the currently most reserved on KYTX (Kyverna Therapeutics, Common Stock)?
